Request a Quote

Cyprotex Highlights - December 2022

Festive header

Sit back and relax in the holidays and read our latest blog articles from the 2022 European Bioanalysis Forum:

  • Is there a place for Echo-MS in high throughput ADME?
  • Application of ultra-fast LC-MS/MS in DMPK screening

Read our blog

Research never stops at Cyprotex. Read on for a recap of some of our scientific content released this year.

New Publications:

New Posters:

Stream our popular webinar: Using Relative Induction Score to Improve Risk Assessment of Clinical CYP3A4 Induction, hosted by our in-house expert Katie Plant:

Watch now

Read the latest news from parent company, Evotec:

  • Exscientia announces CTA approval of a Phase I/II trial for EXS-21546, an A2A receptor antagonist co-developed with Evotec
  • Evotec joins renewable energy heating network Toulouse Energie Durable (“TED”), substantially reducing its carbon emissions
  • Evotec partner Kazia Therapeutics Limited announce the publication of positive pre-clinical data for EVT801
  • Evotec announces further progress in neuroscience collaboration with Bristol Myers Squibb

Read the press releases

Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:

Read the blog

Contact us


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file